M J Friedrich. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Advisory CommitteesAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/metabolismClinical Trials, Phase III as TopicFemaleHeart/drug effectsHeart Diseases/chemically inducedHumansPaclitaxel/adverse effectsPaclitaxel/therapeutic useReceptor, ErbB-2/metabolismStatistics as TopicTrastuzumab
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedReceptor, ErbB-2TrastuzumabPaclitaxel
Year: 2002 PMID： 11983752 DOI： 10.1093/jnci/94.9.650
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506